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to the pharmacist in the present scenario.[1] Taste of 
a pharmaceutical product is an important parameter 
for governing compliance. Thus, taste masking of oral 
pharmaceuticals has become an important tool to improve 
patient compliance and the quality of treatment especially 
in pediatrics and geriatric. Therefore, formulation of taste-
masked products is a challenge to the pharmacists.[2,3]
Metformin hydrochloride is an orally administered 
antihyperglycemic agent, used in the management of type 
2 diabetes (NIDDM) and type 1 diabetes (IDDM). It is a 
very bitter drug and highly soluble in water.[4] The purpose 
of this research was to formulate tasteless complexes of 
metformin with indion 234 and evaluate the molecular 
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ABSTRACT
Metformin hydrochloride is an oral antidiabetic biguinide agent, used in the management of non-insulin-dependent 
(type-2) diabetes mellitus. The purpose of present work was to formulate tasteless complexes of metformin 
hydrochloride with indion 234 and to evaluate molecular properties of drug complexes. The drug loading onto 
ion-exchange resin was optimized for mixing time, activation, effect of pH, mode of mixing, ratio of drug to resin, 
and temperature. Drug resin complexes (DRC) were evaluated for taste masking and characterized by x-ray 
diffraction study and infrared spectroscopy. Metformin hydrochloride release from DRC is obtained at salivary 
and gastric pH and in the presence of electrolytes. The efficient drug loading was evident in batch process using 
activated indion 234 with a pH of 3.5 and drug-resin ratio of 1:1.2, while temperature enhances the complexation 
process. Infrared spectroscopy revealed complexation of –NH (drug) with indion 234. DRC are amorphous in 
nature. Drug release from DRC in salivary pH was insufficient to impart bitter taste. Volunteers rated the complex 
as tasteless and agreeable. Complete drug release was observed at gastric pH in 3 h. The drug release was 
accelerated in the presence of electrolytes. Indion 234 is inexpensive, and the simple technique is effective for 
bitterness masking of metformin.   
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INTRODUCTION 
Undesirable taste is one of several important formulation 
problems that are encountered with certain drugs. The 
problem of bitter and obnoxious taste of it is a challenge 
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properties of drug complexes. Indion 234 is an inexpensive 
resin, and a simple, rapid, and cost-effective method was 
attempted. Drug complexation with ion exchange resins 
is mentioned in certain patents; however, the molecular 
properties of drug resinate and the effect of electrolytes 
on drug release from complex have not been investigated 
much.[5-7] The natural variations in pH can be used 
advantageously to prepare complexes that remain stable in 
the mouth without affecting gastric release. Metformin has 
requisite aqueous solubility, pKa (11.5), and exchangeable 
secondary amine moiety. Indion 234, a water-insoluble, 
high molecular weight, polycarboxylic acid resin is a highly 
porous indigenous resin. A batch process of complexation 
is optimized with reference to drug loading, temperature, 
and pH. The molecular properties of optimized complex 
and the effect of electrolyte on drug release are reported.
MATERIALS AND METHODS
Material
Metformin hydrochloride–IP was a Gift sample from Zim 
Laboratories (Nagpur, India). Indion 254 and Indion 264 
were obtained from Ion Exchange India Ltd (Mumbai, 
India). Sodium chloride, calcium chloride, and other 
chemicals of ultrapure grade were purchased locally. 
Methods
Preliminary evaluation of  resin   
Accurately weighed (1 g) resin samples were kept in oven 
(previously heated to 100 °C) for 24 h and weighed. 
The difference in the weight before and after drying 
gave moisture content. Indion 234 particle diameter was 
measured microscopically. Water absorption time was 
obtained by keeping 500 mg of indion 234 in contact 
with 1 mL of water in a Petri dish. The time required for 
complete water absorption was recorded.
Preparation of  resinate
Resinates were prepared using the batch process.[8,9] The 
resin was rewashed with water until neutral pH was reached. 
DRC was prepared by placing 100 mg of activated resin in 
a beaker containing 50 mL of deionized water. Accurately 
weighed metformin hydrochloride was added and stirred 
for 180 min. The mixture was filtered through Whatman 
filter paper no.41 and residue was washed with 50 mL of 
deionized water. Unbound drug in filtrate was estimated 
at 233.5 nm and drug loading efficiency was calculated.[10]
Optimization of  metformin hydrochloride–Indion 234 complexation
The drug loading on to resin was optimized for various 
parameters such as mixing time, activation, effect of 
pH, mode of mixing, ratio of drug: resin and effect of 
temperature. These parameters were studied and optimized 
for the maximum amount of drug loading.
Effect of  stirring time on drug loading
For optimization of stirring time on drug loading, accurately 
weighed metformin hydrochloride (100 mg) was added to 
100 mg of resin and slurred in 50 mL of deionized water. 
Six batches with a stirring time of 30, 60, 90, 120, 180, and 
240 min were processed. Amount of bound drug at the 
end was estimated at 233.5 nm by UV spectroscopy and the 
time required for maximum loading of drug was optimized.
Effect of  resin activation
Indion 234 placed on a Whatman filter paper in a funnel 
was washed with deionized water and subsequently with 
1N HCl. The resin was rewashed with water until neutral 
pH was reached. Drug: resin complexes were prepared by 
placing 100 mg of acid-activated resin in a beaker containing 
50 mL deionized water. Metformin hydrochloride (100 mg) 
was added to resin slurry with magnetic stirring for 3 h. On 
filtration, the residue was washed with 50 mL of deionized 
water. Unbound drug in filtrate was estimated at 233.5 nm. 
Similarly, alkali activation of Indion 234 was performed, 
replacing 1 N HCl with 1 N NaOH. Finally, Indion 234 
was also activated with combined treatment of 1 N HCl 
and 1 N NaOH solutions. The drug loading efficiency of 
activated resin was evaluated spectrophotometrically. 
Effect of  pH on complex formation
For optimization of pH, weighed, 100 mg of drug was 
added to 100 mg of activated resins in 50 mL of distilled 
water. The pH of solutions were adjusted at 2, 3, 3.5, 4.0, 5, 
and 6.0 stirred for 3 h and the drug content was determined.
Effect of  mode of  mixing on drug loading
For optimization of mode of mixing, Rotary shaker and 
Magnetic stirrer were used. All activated resins (100 mg) in 
50 mL of distilled water and about 100 mg of drug. The 
pH was adjusted at 3.5 and drug content was determined. 
Optimization of  drug:resin ratio
For optimization of ratio of drug: resin, three batches 
were prepared containing drug-resin in the ratio of 1:1, 1:2, 
1:3. Accurately weighed metformin hydrochloride (as per 
1:1, 1:2, and 1:3, drug:resin ratio) was added in 50 mL of 
deionized water. The pH was maintained at 3.5 and stirred 
for 3 h. The mixture was filtered and residue was washed 
with 50 mL of deionized water. Unbound drug in filtrate 
was estimated at 233.5 nm and drug loading efficiency was 
calculated.
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Effect temperature on complex formation
For optimization of temperature on drug loading, 
accurately weighed metformin hydrochloride (100 mg) 
was added to 120 mg of activated resin and slurred in 50 
mL of deionized water at 30°C, 35°C, 40°C, 50°C, and 
60°C using temperature-controlled magnetic stirring for 
180 min. The pH was maintained at 3.5 and the effect of 
temperature on drug loading was studied.
Molecular properties of  drug resin complex
Infrared spectra of metformin hydrochloride, indion 234, 
and DRC (optimized ratio) were recorded over the wave no. 
4000 to 400 cm-1 to check the interaction in the resinate on 
Jasco Dispersive type FT-IR spectrophotometer using the 
KBr disk technique. Then the spectra were comparatively 
analyzed for drug interaction. 
The powder x-ray diffraction patterns (XRDP) of 
metformin hydrochloride, indion 234, and DRC (optimized 
ratio) were subjected to x-ray diffraction study for the 
confirmation of complex formation. X-ray diffraction 
studies were carried out on Phillips analytical X-ray BV 
(pw1710) using Cu anode 40 KV voltage and 30 mA 
current.
Taste evaluation of  solid drug: resin complex
Drug resin complex (1:1.2) was subjected to sensory 
evaluation by a panel of nine members using the time 
intensity method. The pure drug without complexation 
with ion exchange resin was used as control in this study. 
Sample equivalent to 200 mg (dose of drug) was held in 
mouth for 10 s. Bitterness was recorded instantly and 
then after 20, 30, 40, 50, and 60 min.[11] The evaluation 
was performed by classifying bitter taste into five classes. 
Level 0: No bitter taste is sensed, 1: Acceptable bitterness, 
2: Slightly bitterness, 3: Moderately bitterness Level 4: 
Strongly bitterness. Descriptive statistics mean and standard 
deviation were calculated for all variables as shown in   
Table 1. The paired t-test was applied using INSTAT 
software. P-value < 0.05 has been considered as statistical 
significant level.
Drug release from DRC
Drug release from DRC (1:1.2) in deionized water was 
determined using USP type II apparatus (paddle type) at 100 
rpm with temperature of 37 °C ± 0.5 °C. DRC equivalent 
to 200 mg of drug was weighed accurately and added to 
900 mL deionized water. Drug release was performed for 
30 min. A 5 mL sample removed from mixtures each kept 
at 5 to 30 min was filtered and further diluted with 100 mL 
of deionized water and the amount of drug was estimated 
spectrophotometrically. Similarly, drug release from DRC 
was performed at pH 1.2, replacing deionized water with 
900 mL of 0.1 N HCl for 180 min. Drug release from the 
DRC was also performed in 10 mL of pH 6.7 solution by 
adding 200 mg of the DRC to a test tube. The mixture was 
filtered after shaking for 60 s. Further dilutions were made 
and the filtrates were analyzed for drug. 
Drug release from DRC was performed in NaCl solutions 
(0.0015 M, 0.015 M, and 0.15 M) using USP 24 type II 
dissolution apparatus (37°C, 900 mL, 100 rpm) for 30 min. 
Similar study was performed in CaCl2 solutions (0.0015 M, 
0.015 M, and 0.15 M). The effect of electrolytes on drug 
release from DRC is determined.
RESULTS AND DISCUSSION
Optimization of metformin hydrochloride-Indion 234 
complexation
Metformin hydrochloride is an oral antidiabetic biguinide 
agent, used in the management of non-insulin-dependent 
(type-2) diabetes mellitus, is extremely bitter resulting in 
poor patient compliance. Complexation with ion exchange 
resin is a simple and efficient technique of masking the 
bitterness. The drug being soluble in water has desired 
ionization power. The % moisture content in the Indion 
234 resin was found to be 6.2%. The size of Indion 234 
particles obtained was 49 ± 4µm, which is useful for taste 
masking. Substantially small size particles are difficult to 
process and particles greater than 150 µm have a tendency 
to fracture. The water uptake time of Indion 234 was 
found to be 60 s. 
Metformin hydrochloride was loaded on Indion 234 by 
the batch process. Complexation is essentially a process 
of diffusion of ions between the resin and surrounding 
drug solution.[12] As reaction is equilibrium phenomenon, 
maximum efficacy is best achieved in the batch process.
The equilibrium ion exchange in solution occurs 
stoichiometrically and hence is affected by stirring time. 
The percentage drug loading (wt/wt) with a stirring time 
Table 1: Volunteers opinion test for metformin 
hydrochloride before and after taste masking (n=9)
Time 
(seconds)
Before taste  masking 
Mean±SD
After taste masking 
Mean±SD
10 4.0±0.00** 0.2±0.44**




60 1.2 ±0.44** 0
P < 0.001**
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of 30,60,90,120,180, and 240 min was found to be 42.32 % 
± 0.73%, 51.56 % ± 0.82%, 63.73% ± 1.45 %, 68.76 % ± 
0.67%, 74.56% ± 0.92 %, and 75.73% ± 0.45%, respectively. 
This finding may indicate the significant involvement of 
Van Der Waals forces or chemisorption taking place 
along with drug exchange during complexation.  [13] Hence, 
180 min contact time between drug and resin could be 
optimized to equilibrate the ion exchange process to 
achieve maximum drug loading. 
Highest drug binding on resin was achieved when activated 
with both acid-alkali treatments. The percentage drug 
loading with inactivated resin, treated with acid, alkali, and 
combination thereof was found to be 74.56% ± 0.92%, 
82.78% ± 1.19%, 80.93% ± 0.34%, and 83.62% ± 0.94% 
wt/wt, respectively. Highest drug binding on resin was 
achieved when activated with both acid-alkali treatments. 
Impurity associated with industrial scale manufacture or 
absorbed during storage or handling may be neutralized 
by treating with combined solution. The combined resin 
activation exposed the exchangeable groups producing 
rapid drug exchange and hence higher drug binding. 
Metformin-Indion 234 complexation involves the exchange 
of ionizable drug and metal ions in resin. Such a mode of 
complexation between amino group of metformin and 
–COO-K+ functionality of Indion 234 can be affected 
by the pH of the reacting media. The complexation was 
enhanced with increasing pH from 2 to 4 as shown in 
Figure 1. A maximum of 87.90% ± 0.62% wt/wt drug 
loading was obtained at pH 3.5. As pH increased above 
4, the percentage drug loading decreased. The pH of the 
solution affects both solubility and the degree of ionization 
of drug and resin. The results can be attributed to the 
fact that cationic drug is ionized at lower pH value and 
hence demonstrate high binding capacity, while at higher 
pH protonated fraction of cationic drug decreases and 
interaction with resin also decreases.[14-16] Hence, metformin 
hydrochloride as a cationic drug will have maximum 
solubility and complete ionization in this range. Decrease 
complexation at lower pH i.e. below 2 is due to excess H+ 
ions in solution which have more binding affinity to the 
–COO- group of resin and compete with drug for binding.
Complexation was found to be optimum in case of stirring, 
a maximum of 87.26% ± 0.62% wt/wt and in case of 
shaking 75.83% ± 1.23% wt/wt. This finding may indicate 
the significant involvement of Van Der Waals forces taking 
place along with drug exchange during complexation. 
The drug-loading efficiency for a drug-resin ratio 1:1, 1:2, 
and 1:3 of the batch process was 87.26% ± 0.62%, 94.56% 
± 0.68%, and 94.85% ± 1.51% wt/wt. It is due to the fact 
that, increase in the amount of resin increases the amount 
of drug adsorbed from the solution. A 7 % wt/wt increase 
of loading efficiency was observed in batch process, when 
the drug-resin ratio was changed from 1:1 to 1: 2. Hence, 
the drug loading performed at an intermediate drug-resin 
ratio of 1:1.2, 1: 1.4, 1:1.6, and 1:1.8 was found to be 
94.30% ± 1.56%, 94.52% ± 0.23%, 94.20% ± 0.87%, 
and 94.26% ± 0.37% wt/wt, respectively. Although drug 
binding was comparable, metformin dose ranging from 
300 to 500 mg and the higher resin ratio in the latter (1:1.4) 
would be difficult to accommodate in tablet formulations. 
The drug-resin ratio of 1:1.2 has optimum drug loading. 
Santos and Ghaly[17] have reported a loading efficiency of 
38.6% for cimetidine using amberlite 69. In the case of 
metformin hydrochloride and Indion 234, a drug-loading 
efficiency of more than 87% wt/wt was achieved even with 
a drug-resin ratio of 1:1. 
The % drug loading (w/w) with temperature of 30°C, 
35°C, 40°C, 50°C, and 60°C was found to be 91.24 ±1.86, 
92.67% ± 0.45%, 95.36 ±1.24, 97.34±1.25, and 97.42 ± 
0.86, respectively. These figures reveal that as temperature 
increases percentage of drug loading also increases rapidly 
upto 50°C. Increase in temperature above 50 °C did not 
further increase the percentage drug loading. Increased 
temperature during complexation increases ionization 
of drug and resin. Higher temperatures tend to increase 
the diffusion rate of ions by decreasing the thickness of 
exhaustive exchange zone.[18] Also at increased temperature, 
swelling of resin takes place. Due to swelling ionic sites are 
open for exchange of counter ions.[19]
Molecular properties of drug-resin complexes
The infrared spectra of drug, Indion 234 resin, and 
resinate are depicted in Figure 2. FT-IR spectra of drug 
show a prominent peak at 1028 cm-1 corresponding to  Figure 1: Effect of reaction medium pH on percent drug loading.116   Journal of Young Pharmacists Vol 3 / No 2
30 min, indicating the stability of complexes. In vitro drug 
release in average salivary pH of 6.7 was less than 8% 
within 60 s. The presence of exchangeable ions of ionizable 
electrolytes in the salivary fluid may be responsible for 
this release. The DRC is stable in salivary pH for a period 
of administration. The amount released is insufficient to 
impart bitter taste, while the formulation passes through 
the mouth to further parts of the gastrointestinal (GI) 
tract. At gastric pH 1.2, 74% of metformin was released 
within 120 min, and the release was complete in 180 min. 
The hypothesis that the drug-release equilibrium, similar 
to drug loading, is highly dependent on the physiological 
pH can be applied for taste masking without affecting the 
dosage form characteristics.
The exchange process of drug release follows Equation 1.
Resin– – Drug + + X+ → Resin– – X+ + Drug+ ,  (1)
Where, X+ represents the ions in the GI tract.
Particle diffusion and film diffusion are sequential steps 
in drug release by the ion exchange process.[20] Indion 
234-metformin complex hydrates by water absorption and 
then swells in diffusion media, and the subsequent exchange 
process releases the drug. There was no drug release in 
plain deionized water because metformin hydrochloride 
was completely ionized and therefore bound to the resin. 
Drug release at pH 6.7 and cation concentration of 40 
Figure 2: FT-IR spectra of (a) metformin hydrochloride, (b) Indion 234 resin, (c) Indion 234 resinate.
the NH stretching in a secondary amine. Indion 234 
shows characteristic peaks at 1674 cm-1, at 1764 cm-1 
corresponding to –C = O stretching of aryl acids, and at 
1602 cm-1 due to aromatic C=C stretching. Numbers of 
overtone peaks were observed at 2308 and 2347 cm-1. The 
absence of peak at 1028 cm-1 in DRC (1:1.2) confirms the 
complexation of the secondary amine group in the drug 
with resin. 
The x-ray diffraction study of metformin hydrochloride 
shows highly crystalline nature. Resin Indion 234 showed 
amorphous nature. The molecular state of the drug 
prepared as DRC shows a hollow diffused pattern and the 
absence of drug peaks having noncrystalline characteristics. 
This finding confirms that the entrapped drug is dispersed 
monomolecularly in the resin bead and this might be 
because of entrapment of drug molecule in the polymer 
matrix of the resins. From all the evidences it can be 
concluded that the drug resinate was a chemical complex 
[Figure 3]. Studies have shown that the molecules of the 
entrapped drug changes from crystalline to amorphous 
state.
Drug release from the drug-indion complex
Metformin release from the drug-resin adsorbate was 
observed in deionized water for 30 min, in average salivary 
pH of 6.7, and at gastric pH of 1.2, separately. Less than 
0.8% wt/vol of drug was released in deionized water in 
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Figure 4: Effect of electrolytes on metformin hydrochloride release 
from complexes.
Figure 3: X-ray diffraction pattern of (a) metformin hydrochloride, (b) Indion 234 resin, (c) Indion-234 resinate.
mEq/L in a short period of ingestion does not alter 
the exchange process. The complexation of metformin 
hydrochloride with Indion 234 produces amorphous 
tasteless drug resinates.
Taste evaluation in volunteers confirmed that the taste 
of ciprofloxacin was masked by complexing with Indion 
234. The majority of the volunteers found the DRC to be 
tasteless and agreeable. When DRC is exposed to a low 
pH, it causes dissociation of the complex. The presence of 
H+ ion in the medium causes displacement of metformin, 
thus facilitating drug release. This finding has been well 
supported by XRPD data and confirmed by in vitro drug 
release in salivary pH.
Figure 4 shows the effect of the ionic strength of salts 
on drug release from DRC. It may be noted that an 
insignificant amount of drug was released (0.8%) in plain 
deionized water. The drug release from complex increased 
as the concentration of electrolyte increased in the medium. 
In a solution of 0.0015 M and 0.015 M NaCl, drug release 
showed an insignificant difference. However, increased 
release of 23.6% was observed in 0.15 M NaCl solution. 
Similarly, increasing the CaCl2 concentration in the medium 
increased the drug release from DRC. The effect of divalent 
calcium ions was more pronounced than monovalent 
sodium ions. Drug release of 12 %, 42%, and 55% within 
30 min was observed with respect to 0.0015 M, 0.015 M, 
and 0.15 M CaCl2 in solution. 
Electrostatic interactions govern the equilibrium 
distribution of the drug species between the resin and 
solution phases.[21-23] The influence of salt concentration 
on the release rate can be explained by solute diffusion. 
The metformin release from DRC is controlled by an ion 
exchange mechanism. The exchange rate is dominated 
by the rate at which the competing ions diffuse from the 
media to resin. Solute diffusion is driven by a concentration 
gradient. At high salt concentration, the concentration 
gradient is greater, resulting in faster diffusion of ions, and 
thereby a higher release rate. Valency of the counter ions 
influences exchange capacity. The rate of sorption of the 
divalent calcium ions was much faster as compared with 
Bhoyar and Amgaonkar: Molecular properties of metformin hydrochloride-Indion 234 complexes118   Journal of Young Pharmacists Vol 3 / No 2
Na+ ions, which are less firmly bound. Also, the selectivity 
of carboxylic acid resins is higher for divalent calcium ions. 
Even though larger size Ca2
+ ions are expected to diffuse 
slowly, their valency enhances the drug release. Drug release 
is a reverse process to drug loading, both involve ions that 
compete for ionic binding sites with the drug.
CONCLUSION
The batch process of complexing metformin hydrochloride 
with indion 234 produced efficient drug loading. The drug 
release from the DRC increased with the salt concentration, 
and the effect was more pronounced with divalent calcium 
ions. The volunteers rated the complexes as tasteless and 
agreeable.
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